All Locations

Top Companies in Switzerland

343 companies based in Switzerland, sorted by total funding raised.

PharvarisIPO

Pharvaris is a clinical-stage company focused on the discovery and development of treatments for ...

Zug, Switzerland51–200Biotech, Healthcare
Private Equity·$216.0M·Jun 2023
Ecorobotix

AI-driven precision agriculture robotics

Yverdon-les-Bains, Switzerland201–500Artificial Intelligence, Climate Tech
Series D·$205.3M·Oct 2025
Polkadot

Polkadot is a multichain blockchain protocol enabling interoperability between independent blockc...

Zug, Switzerland51–200Crypto & Web3
Venture Round·$193.1M·Jul 2020
GlycoEra

Selective glycan-remodeling for enhanced antibody therapy

Wädenswil, Switzerland11–50Biotech, Healthcare
Series B·$179.0M·May 2025
SWISSto12

Multi-orbit satellite antenna and payload manufacturer.

Renens, Switzerland51–200Space Tech
Series C·$173.2M·Jul 2026
21.co

Parent company of 21Shares, the world's largest provider of crypto exchange-traded products (ETPs).

Zurich, Switzerland51–200Crypto & Web3, Fintech
Venture Round·$171.0M·Sep 2022
Vaderis Therapeutics

A Basel, Switzerland-based provider of targeted therapies for rare vascular diseases

Basel, Switzerland11–50Biotech, Healthcare
Series B·$171.0M·Aug 2026
CRISPRIPO

A Basel, Switzerland and Boston, MA-based biopharmaceutical company created to translate CRISPR-C...

Zug, Switzerland201–500Biotech, Healthcare
Series B·$167.0M·Jan 2016
DFINITY

The DFINITY Foundation's mission is to build, promote, and maintain the Internet Computer — and b...

Zurich, Switzerland51–200Crypto & Web3, Cloud
Series C·$163.0M·Aug 2018
SportradarIPO

Sportradar is a leading global sports technology company providing data, content, and integrity s...

St. Gallen, Switzerland1001–5000Analytics, sports data
Private Equity·$159.0M·Sep 2021
Addex TherapeuticsIPO

Addex Therapeutics is a biopharmaceutical company focused on the development of novel, orally ava...

Plan-les-Ouates, Switzerland11–50Biopharmaceutical, Biotech
Extension Round·$155.9M·Aug 2022
BoardAcquired

Enterprise planning platform combining business intelligence, corporate performance management, a...

Chiasso, Switzerland201–500Business Intelligence, Data & Analytics
Series A·$153.8M·Jun 2026
ANYbotics

Developer of ANYmal autonomous legged robots for industrial inspection in hazardous environments,...

Zurich, Switzerland201–500Artificial Intelligence, Automation
Extension Round·$152.5M·Sep 2025
B
Bancor/BNT

Decentralized finance protocol enabling on-chain trading and automated liquidity; creators of the...

Zug, Switzerland11–50Crypto & Web3, Fintech
Equity Crowdfunding·$152.3M·Jun 2017
VectivBioAcquired

GLP-2 analog apraglutide for short bowel syndrome

Basel, Switzerland11–50Biotech, Healthcare
Venture Round·$145.0M·Jan 2023
Beekeeper

Beekeeper is a mobile-first frontline success platform connecting deskless workers with communica...

Zurich, Switzerland201–500SaaS
Growth Equity·$138.0M·Mar 2025
BeOne Medicines Ltd.IPO

BeOne Medicines, formerly BeiGene, is a global oncology company committed to advancing cancer car...

Basel, Switzerland5001–10000Biotech, Healthcare
Series A·$132.5M·Jan 2013
Asceneuron

Tau-targeting small molecules for neurodegeneration

Eysins, Switzerland11–50Biotech, Healthcare
Series C·$130.0M·Jul 2024
WISeKey International Holding LtdIPO

Global cybersecurity leader providing digital identity and IoT solutions using Blockchain, AI and...

Geneva, Switzerlandenterprise software, Cybersecurity
Venture Round·$122.0M·Jan 2016
ObsEvaClosed

ObsEva is a clinical stage biopharmaceutical company focusing on the development of a novel gener...

Geneva, Switzerland11–50Biotech, Reproductive Health
Venture Round·$111.0M·Sep 2020
ImmunOs Therapeutics

Swiss biotech developing novel human immunomodulatory proteins for cancer treatment, focused on i...

Basel, Switzerland11–50Biotech
Series C·$102.5M·Sep 2024
AC Immune SAIPO

Clinical-stage biopharmaceutical company and global leader in developing precision medicine for n...

SwitzerlandBiotech, Healthcare
Private Equity·$100.1M·Dec 2016
MindMaze

Swiss neurotechnology company developing digital therapeutics and neurorehabilitation systems for...

Lausanne, Switzerland51–200Artificial Intelligence, Healthcare
Venture Round·$100.0M·May 2026
Neural Concept

AI-native engineering and design software platform for simulation-driven product development.

Lausanne, Switzerland51–200Artificial Intelligence, SaaS
Growth Equity·$100.0M·Dec 2025
TherachonAcquired

Developing a novel biologic therapy for achondroplasia, the most common form of dwarfism

Basel, Switzerland11–50Biotech, Healthcare
Series B·$100.0M·Aug 2018